The frequencies of MDSC and CD14+CD15− mMDSCs in PBMC from 30 untreated patients with MG did not significantly change compared to those in 30 HCs (1.5 ± 1.1% vs. 1.4 ± 0.5%, p = 0.061, Figure 2B and 0.21 ± 0.26% vs. 0.2 ± 0.094, p = 0.85, Figure 2C, respectively). The gene discussed is CD14; the disease is myasthenia gravis.